Table 3. Associations of ultrasound-diagnosed NAFLD with C-IMT in type 1 diabetic individuals stratified according to sex distribution, presence/absence of the metabolic syndrome or to the median values of age, diabetes duration, body mass index, systolic blood pressure, hemoglobin A1c and with insulin therapy alone.
Variable | β | 95% CI | P value |
---|---|---|---|
Age < 49 years(n = 354) | 0.357 | 0.103–0.202 | <0.001 |
Age ≥ 49 years(n = 368) | 0.245 | 0.074–0.180 | <0.001 |
Men (n = 371) | 0.104 | 0.004–0.124 | 0.036 |
Women (n = 351) | 0.251 | 0.071–0.172 | <0.001 |
Without the metabolic syndrome (n = 448) | 0.199 | 0.076–0.208 | <0.001 |
With the metabolic syndrome (n = 274) | 0.141 | 0.011–0.110 | 0.016 |
Diabetes duration < 5 years (n = 356) | 0.247 | 0.074–0.181 | <0.001 |
Diabetes duration ≥ 5 years (n = 366) | 0.122 | 0.012–0.125 | 0.018 |
BMI < 21.5 kg/m2 (n = 359) | 0.196 | 0.065–0.211 | <0.001 |
BMI ≥ 21.5 kg/m2 (n = 363) | 0.143 | 0.021–0.121 | 0.005 |
HbA1c < 8.7 (n = 357) | 0.264 | 0.083–0.194 | <0.001 |
HbA1c ≥ 8.7 (n = 365) | 0.276 | 0.089–0.201 | <0.001 |
Systolic blood pressure < 120 (n = 336) | 0.316 | 0.110–0.228 | <0.001 |
Systolic blood pressure ≥ 120 (n = 386) | 0.113 | 0.010–0.112 | 0.019 |